Top

Obesity Surgery

Published in:

01-04-2020 | Sleeve Gastrectomy | Original Contribution

Effects of Sleeve Gastrectomy with Transit Bipartition on Glycemic Variables, Lipid Profile, Liver Enzymes, and Nutritional Status in Type 2 Diabetes Mellitus Patients

Author: Fatih Can Karaca

Published in: Obesity Surgery | Issue 4/2020

Abstract

Background

Sleeve gastrectomy with transit bipartition (SG + TB) surgery is an effective treatment modality for the patients with type 2 diabetes mellitus (T2DM). Here, we aimed to present the 1-year follow-up data of our patients with T2DM who underwent SG + TB.

Methods

We evaluated the follow-up results of 45 patients and evaluated the remission status of T2DM. Additionally, biochemical variables including lipid status, liver function and nutritional status were presented.

Results

A total of 40 T2DM remissions occurred among the 45 patients (88.8%). The complete remission was present in 35 of the patients at the end of the postoperative first year. The lipid profile markers improved following the first postoperative month. The levels of the liver enzyme alanine aminotransferase (ALT) decreased after the first postoperative month, while aspartate aminotransferase (AST) levels did not alter significantly during the follow-up period. We did not observe a change regarding albumin and vitamin B12 levels following the surgery.

Conclusion

SG + TB is a convenient and therapeutic method for the treatment of T2DM, along with the improvement in lipid profile and liver enzyme levels.

Available only for authorised users

WHO. Global report on diabetes. 2006. Available at: https://www.who.int/diabetes/global-report/en/. Accessed on 21/08/2019

Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world - a growing challenge. N Engl J Med. 2007;356:213–5. https://doi.org/10.1056/NEJMp068177.CrossRefPubMed

Rubino F, Nathan DM, Eckel RH, et al. Cummings DE; delegates of the 2nd diabetes surgery summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77. https://doi.org/10.2337/dc16-0236.CrossRefPubMed

Santoro S, Malzoni CE, Velhote MCP, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based procedure for morbid obesity. Obes Surg. 2006;16(10):1371–9. https://doi.org/10.1381/096089206778663841.CrossRefPubMed

Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012 Jul;256(1):104–10. https://doi.org/10.1097/SLA.0b013e31825370c0.CrossRefPubMed

Aminian A, Brethauer SA, Andalib A, et al. Individualized metabolic surgery score: procedure selection based on diabetes severity. Ann Surg. 2017;266(4):650–7. https://doi.org/10.1097/SLA.0000000000002407.CrossRefPubMed

Ghio B, Jiménez A, Corcelles R, et al. Midterm effects of bariatric surgery in patients with insulin-treated type 2 diabetes. Surg Obes Relat Dis. 2016;13:2004. https://doi.org/10.1016/j.soard.2016.12.030.CrossRefPubMed

Santoro S. From bariatric to pure metabolic surgery: new concepts on the rise. Ann Surg. 2015;262:79–80.CrossRef

Yormaz S, Yılmaz H, Ece I, et al. Laparoscopic Ileal interposition with diverted sleeve gastrectomy versus laparoscopic transit bipartition with sleeve gastrectomy for better glycemic outcomes in T2DM patients. Obes Surg. 2018;28(1):77–86. https://doi.org/10.1007/s11695-017-2803-6.CrossRefPubMed

10.

American Diabetes Association. Standards of medical care in diabetes-2012. Diabetes Care. 2012;35(Suppl 1):S11–63. https://doi.org/10.2337/dc12-s011.CrossRef

11.

Renquist K, Jeng G, Mason EE, et al. Calculating Follow-up Rates. Obes Surg. 1992;2:361–7. https://doi.org/10.1381/096089292765559963.CrossRefPubMed

12.

Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32(11):2133–5. https://doi.org/10.2337/dc09-9036.CrossRefPubMedPubMedCentral

13.

Matsuzaka T, Shimano H. Molecular mechanisms involved in hepatic steatosis and insulin resistance. J Diabetes Investig. 2011;2(3):170–5. https://doi.org/10.1111/j.2040-1124.2011.00111.x.CrossRefPubMedPubMedCentral

14.

Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–51. https://doi.org/10.1056/NEJMoa1600869.CrossRefPubMedPubMedCentral

15.

Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. https://doi.org/10.1056/NEJMoa1200225.CrossRefPubMedPubMedCentral

16.

Dixon JB, le Roux CW, Rubino F, et al. Bariatric surgery for type 2 diabetes. Lancet. 2012;379(9833):2300–11. https://doi.org/10.1016/S0140-6736(12)60401-2.CrossRefPubMed

17.

Azevedo FR, Santoro S, Correa-Giannella ML, et al. Caramelli B.a prospective randomized controlled trial of the metabolic effects of sleeve gastrectomy with transit bipartition. Obes Surg. 2018;28(10):3012–9. https://doi.org/10.1007/s11695-018-3239-3.CrossRefPubMed

18.

Golomb I, Ben David M, Glass A, et al. Long-term metabolic effects of laparoscopic sleeve gastrectomy. JAMA Surg. 2015;150(11):1051–7. https://doi.org/10.1001/jamasurg.2015.2202.CrossRefPubMed

19.

Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care. 2013 Aug;36(8):2175–82. https://doi.org/10.2337/dc12-1596.CrossRefPubMedPubMedCentral

20.

Celik A, Ugale S. Functional restriction and a new balance between proximal and distal gut: the tools of the real metabolic surgery. Obes Surg. 2014;24(10):1742–3. https://doi.org/10.1007/s11695-014-1368-x.CrossRefPubMedPubMedCentral

21.

Lee WJ, Almulaifi AM, Tsou JJ, et al. Duodenal–jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11(4):765–70. https://doi.org/10.1016/j.soard.2014.12.017.CrossRefPubMed

22.

Chao SH, Lin CL, Lee WJ, et al. Proximal Jejunal bypass improves the outcome of gastric clip in patients with obesity and type 2 diabetes mellitus. Obes Surg. 2019;29(4):1148–53. https://doi.org/10.1007/s11695-018-3607-z.CrossRefPubMed

23.

Lin S, Guan W, Yang N, et al. Short-term outcomes of sleeve gastrectomy plus jejunojejunal bypass: a retrospective comparative study with sleeve gastrectomy and Roux-en-Y gastric bypass in Chinese patients with BMI ≥ 35 kg/m2. Obes Surg. 2019;29(4):1352–9. https://doi.org/10.1007/s11695-018-03688-1.CrossRefPubMed

24.

Andrès E, Serraj K, Zhu J, et al. The pathophysiology of elevated vitamin B12 in clinical practice. QJM Int J Med. 2013;106(6):505–15. https://doi.org/10.1093/qjmed/hct051.CrossRef

25.

Aminian A, Chang J, Brethauer SA, et al. ASMBS updated position statement on bariatric surgery in class I obesity (BMI 30-35 kg/m2). Surg Obes Relat Dis. 2018;14(8):1071–87. https://doi.org/10.1016/j.soard.2018.05.025.CrossRefPubMed

Title: Effects of Sleeve Gastrectomy with Transit Bipartition on Glycemic Variables, Lipid Profile, Liver Enzymes, and Nutritional Status in Type 2 Diabetes Mellitus Patients
Author: Fatih Can Karaca
Publication date: 01-04-2020
Publisher: Springer US
Keywords: Sleeve Gastrectomy
Diabetes
Type 2 Diabetes
Published in: Obesity Surgery / Issue 4/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-019-04326-0

At a glance: The STEP trials

Springer Medicine

Effects of Sleeve Gastrectomy with Transit Bipartition on Glycemic Variables, Lipid Profile, Liver Enzymes, and Nutritional Status in Type 2 Diabetes Mellitus Patients

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2020

Early Outcomes of Primary SADI-S: an Australian Experience

Does FMI Correlate Better than BMI with the Occurrence of Metabolic Changes in Obese Patients? Study Based on 2007 Consecutive Mexican Patients

Some Caveats when Interpreting Surgical Mouse Models of Vertical Sleeve Gastrectomy

Impact of Adherence to the ERAS® Protocol on Short-term Outcomes after Bariatric Surgery

Midterm Outcome of Laparoscopic Sleeve Gastrectomy in Asians: a Systematic Review and Meta-analysis

Bariatric Surgery in Cirrhotic Patients: Is It Safe?